Literature DB >> 33155086

Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group.

Abdullah Sumnu1, Kultigin Turkmen2, Egemen Cebeci3, Aydin Turkmen4, Necmi Eren5, Nurhan Seyahi6, Aysegul Oruc7, Fatih Dede8, Ülver Derici9, Taner Basturk10, Garip Şahin11, Murat Sipahioglu12, Gulizar Manga Sahin13, Erhan Tatar14, Belda Dursun15, Savas Sipahi16, Mürvet Yılmaz17, Gultekin Suleymanlar18, Sena Ulu19, Ozkan Gungor20, Sim Kutlay21, Zerrin Bicik Bahçebaşı22, İdris Sahin23, Ilhan Kurultak24, Can Sevinc25, Zulfikar Yilmaz26, Rumeyza Turan Kazancioglu27, Caner Cavdar28, Ferhan Candan29, Zeki Aydin30, Deren Oygar31, Bulent Gul32, Bulent Altun33, Saime Paydas34, Sami Uzun3, Zulal Istemihan35, Metin Ergul5, Mevlut Tamer Dincer6, Mustafa Gullulu7, Serhan Piskinpasa8, Omer Faruk Akcay9, Abdulkadir Unsal10, Sumeyra Koyuncu12, Mahmut Gok13, Savas Ozturk3.   

Abstract

PURPOSE: Hematuria is one of the most common laboratory findings in nephrology practice. To date, there is no enough data regarding the clinical and histopathologic characteristics of primary glomerular disease (PGD) patients with hematuria in our country.
METHODS: Data were obtained from national multicenter (47 centers) data entered into the Turkish Society of Nephrology Glomerular Diseases (TSN-GOLD) database between May 2009 and June 2019. The data of all PGD patients over the age of 16 years who were diagnosed with renal biopsy and had hematuria data were included in the study. Demographic characteristics, laboratory and biopsy findings were also recorded.
RESULTS: Data of 3394 PGD patients were included in the study. While 1699 (50.1%) patients had hematuria, 1695 (49.9%) patients did not have hematuria. Patients with hematuria had statistically higher systolic blood pressure, serum blood urea nitrogen, creatinine, albumin, levels and urine pyuria. However, these patients had statistically lower age, body mass index, presence of hypertension and diabetes, eGFR, 24-h proteinuria, serum total, HDL and LDL cholesterol, and C3 levels when compared with patients without hematuria. Hematuria was present 609 of 1733 patients (35.8%) among the patients presenting with nephrotic syndrome, while it was presented in 1090 of 1661 (64.2%) patients in non-nephrotics (p < 0.001).
CONCLUSION: This is the first multicenter national report regarding the demographic and histopathologic data of PGD patients with or without hematuria. Hematuria, a feature of nephritic syndrome, was found at a higher than expected in the PGDs presenting with nephrotic syndrome in our national database.

Entities:  

Keywords:  Epidemiology; Glomerular disease; Glomerulonephritis; Hematuria

Year:  2020        PMID: 33155086     DOI: 10.1007/s11255-020-02690-w

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  4 in total

Review 1.  Clinical spectrum and complications of the nephrotic syndrome.

Authors:  C K Abrass
Journal:  J Investig Med       Date:  1997-04       Impact factor: 2.895

2.  A comparison of the clinical and laboratory features of thin basement membrane disease (TBMD) and IgA glomerulonephritis (IgA GN).

Authors:  R Auwardt; J Savige; D Wilson
Journal:  Clin Nephrol       Date:  1999-07       Impact factor: 0.975

Review 3.  The Investigation of Hematuria.

Authors:  Christian Bolenz; Bernd Schröppel; Andreas Eisenhardt; Bernd J Schmitz-Dräger; Marc-Oliver Grimm
Journal:  Dtsch Arztebl Int       Date:  2018-11-30       Impact factor: 5.594

4.  Glomerular disease as a cause of isolated microscopic haematuria.

Authors:  P S Topham; S J Harper; P N Furness; K P Harris; J Walls; J Feehally
Journal:  Q J Med       Date:  1994-06
  4 in total
  2 in total

1.  Clinical and pathologic features of primary membranous nephropathy in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group.

Authors:  Abdulmecit Yildiz; Sena Ulu; Aysegul Oruc; Ali Riza Ucar; Savas Ozturk; Selma Alagoz; Necmi Eren; Ismail Kocyigit; Simal Koksal Cevher; Ali Burak Haras; Abdullah Sumnu; Turgay Arinsoy; Garip Sahin; Gultekin Suleymanlar; Caner Cavdar; Gizem Kumru Sahin; Ilhan Kurultak; Abdulkadir Unsal; Gulizar Sahin; Sinan Kazan; Erhan Tatar; Mehmet Dıkec; Belda Dursun; Hayriye Sayarlioglu; Kultigin Turkmen; Ayse Serra Artan; Nimet Aktas; Zulfikar Yilmaz; Ahmet Behlul; Hamad Dheir; Sim Kutlay; Nurhan Seyahi
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

2.  Trends of primary glomerular disease in Turkey: TSN-GOLD registry report.

Authors:  Cuma Bülent Gül; Mehmet Küçük; Savaş Öztürk; Erol Demir; Necmi Eren; Abdullah Şumnu; Nurhan Seyahi; Mustafa Güllülü; Fatih Dede; Ülver Derici; Yener Koç; Garip Şahin; Oktay Oymak; Gülizar Manga Sahin; Erhan Tatar; Belda Dursun; Hamad Dheir; Süheyla Apaydın; Gültekin Süleymanlar; Sena Ulu; Orçun Altınören; Sim Kutlay; Meral Meşe; İdris Şahin; Sedat Üstündağ; Kültigin Türkmen; Mehmet Emin Yılmaz; Rümeyza Turan Kazancıoğlu; Özcan Uzun; Ferhan Candan; Zeki Aydın; Deren Oygar; Nimet Aktaş; Yunus Erdem; Saime Paydaş; Dilek Taymez; Başak Can; Ahmet Kıykım; Leyla Koç; Siren Sezer; Murat Duranay; Simge Bardak; Lütfullah Altıntepe; Burcu Kaya; Alper Azak; Sebahat Alışır Ecder; Caner Çavdar; Nedim Yılmaz Selçuk
Journal:  Int Urol Nephrol       Date:  2022-02-02       Impact factor: 2.266

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.